Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A broad market index fund offers simple diversification and low costs, making it a practical choice for retirement portfolios seeking steady growth.
28,528 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Iovance surged this week after robust Q4 results and a Philadelphia manufacturing moat highlighted by a 32 day turnar...
Bitcoin dives again after Friday’s jobs data, erasing a midweek rally as risk-off sentiment spreads. Prices hovered a...
In a $520 billion, fragmented remodeling market, larger players use scale and financing access to win more projects, ...
Middleby Corp. launches its most sweeping restructuring in years, slimming the portfolio to focus on core, higher-mar...
Ripple's XRP briefly breached the $1.50 threshold but failed to sustain gains, renewing questions about the next majo...
Ethereum retreats from a rough start to the year, but a key analyst says Crypto Spring has begun. Investors are watch...
Ethereum flirts with a critical level as it trades around the $2,100 mark. A breakdown of $1,800 could accelerate los...
Zcash plunged about 45% after the founder disclosed a vulnerability in the Orchard shielded pool. The flaw, if exploi...
South Korea's crypto scene is under new scrutiny as the south korean police book Bithumb's CEO in a bribery probe lin...
Analysts clash over SpaceX's value as Oppenheimer targets a $250 price, while Michael Burry stays neutral. The debate...
NVIDIA’s market value dips below the $5 trillion threshold as traders reassess AI demand and supply dynamics. Analyst...